Saturday 17 October 2026 Export SBFM’s income statement to Excel — free account

Sunshine Biopharma, Inc.

SBFM Healthcare Drug Manufacturers Specialty & Generic

Sunshine Biopharma, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.3 million, up 4.11% from fiscal 2024. In the quarter to June 2026, revenue fell 1.56%, EPS grew 70.5% and free cash flow grew 49.4%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

0.22 0.01 −4.35%

Follow SBFM

Alert me

Market cap: $990.0K
P/E: 0.0×
Fwd P/E: −0.4×
Dividend yield: —
F-score: 4/9
Altman Z: −1.72
Beneish M: −2.96
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	4	4	4	3	+8 more TTM periods Free account
ROE Full definition →	(21.93%)	(27.33%)	(25.69%)	(24.35%)
ROA Full definition →	(17.78%)	(21.15%)	(19.71%)	(19.47%)
ROIC Full definition →	(26.67%)	(27.08%)	(27.97%)	(27.38%)
Return on Tangible Assets Full definition →	(22.85%)	(31.10%)	(28.50%)	(27.35%)
Average Days of Receivables Full definition →	41.67	41.25	34.78	40.64
Free Cash Flow per Share Full definition →	(4.06)	(13.12)	(14.84)	(17.57)
Free Cash Flow Full definition →	(5.54)	(6.44)	(6.17)	(8.00)
Capital Expenditures Full definition →	(0.18)	(0.73)	(0.84)	(0.88)
Other line items
Cash ROIC Full definition →	(13.41%)	(22.64%)	(19.18%)	(23.89%)
Accounts Receivable Turnover Full definition →	9.27	9.52	9.91	10.12
Accounts Payable Turnover Full definition →	5.11	4.70	4.29	4.86
Inventory Turnover Full definition →	1.96	1.90	1.94	2.09
Average Days of Payables Full definition →	71.89	78.33	85.96	89.59
Days of Inventory on Hand Full definition →	179.59	202.06	204.46	205.30
Tax Rate Full definition →	0.00	0.01	0.00	(0.08)
Research and Development Expense of Revenue Full definition →	0.67%	1.19%	1.66%	1.82%
Selling, General and Administrative Expense of Revenue Full definition →	48.29%	48.65%	48.33%	43.53%
Share Based Compensation of Revenue Full definition →	0.27%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →	0.92	0.95	0.89	1.19
Depreciation/Fixed assets Full definition →	2.17	4.05	3.73	3.20
Capex/Depreciation Full definition →	(0.18)	(0.35)	(0.40)	(0.46)
Revenue per Share Full definition →	25.89	72.35	87.34	81.92
Operating CF per Share Full definition →	(3.92)	(11.64)	(12.82)	(15.63)
Capex per Share Full definition →	(0.13)	(1.49)	(2.01)	(1.94)
Capex to Sales Full definition →	0.01	0.02	0.02	0.02

Show all line items

Columns are period end dates

Stockrow Weekly